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ARTICLE OPEN
STAT3 associates with vacuolar H+-ATPase and regulates
cytosolic and lysosomal pH
Bin Liu1, Johan Palmfeldt2, Lin Lin3, Alexandria Colaço1, Knut K. B. Clemmensen1, Jinrong Huang 4,5,6, Fengping Xu4,5,6, Xin Liu4,6,
Kenji Maeda1, Yonglun Luo 3,4,6 and Marja Jäättelä 1,7
Dysregulated intracellular pH is emerging as a hallmark of cancer. In spite of their acidic environment and increased acid
production, cancer cells maintain alkaline intracellular pH that promotes cancer progression by inhibiting apoptosis and increasing
glycolysis, cell growth, migration, and invasion. Here we identify signal transducer and activator of transcription-3 (STAT3) as a key
factor in the preservation of alkaline cytosol. STAT3 associates with the vacuolar H+-ATPase in a coiled-coil domain-dependent
manner and increases its activity in living cells and in vitro. Accordingly, STAT3 depletion disrupts intracellular proton equilibrium
by decreasing cytosolic pH and increasing lysosomal pH, respectively. This dysregulation can be reverted by reconstitution with
wild-type STAT3 or STAT3 mutants unable to activate target genes (Tyr705Phe and DNA-binding mutant) or to regulate
mitochondrial respiration (Ser727Ala). Upon cytosolic acidiﬁcation, STAT3 is transcriptionally inactivated and further recruited to
lysosomal membranes to reestablish intracellular proton equilibrium. These data reveal STAT3 as a regulator of intracellular pH and,
vice versa, intracellular pH as a regulator of STAT3 localization and activity.
Cell Research (2018) 28:996–1012; https://doi.org/10.1038/s41422-018-0080-0
INTRODUCTION
Tumorigenesis proceeds via an evolutionary process, in which a
succession of genetic changes provide the transforming cells with
a set of acquired capabilities that enable tumor growth and
dissemination.1 These traits include sustained proliferative signal-
ing, metastatic capacity, activation of angiogenesis, replicative
immortality, reprogrammed energy metabolism, as well as escape
from cell death, growth suppressors, and immune destruction.
Besides these well-established hallmarks of cancer, the pH
gradient reversal, i.e., acidiﬁcation of extracellular pH (pHe) from
∼7.4 in normal cells to 6.5–7.0 in cancer cells, while maintaining
alkaline cytosolic pH (pHc) of normal cells (∼7.2) or further
alkalizing it to values as high as 7.6 in cancer cells, is emerging as a
universal hallmark of cancer observed in malignant tumors
regardless of the pathology, genetics, and origin.2–4 The reversal
of the pH gradient is an early event in tumorigenesis and its
maintenance reinforces metabolic adaptation, tumor cell survival,
invasion, immune evasion, and drug resistance. For instance,
glycolytic ﬂux essential for metabolic reprogramming is stimulated
by alkaline cytosol,3 whereas the activation of apoptosis-inducing
caspases depends on mild acidiﬁcation of the cytosol.5 In parallel,
the acidiﬁcation of the extracellular space promotes tumor
immune escape and effective proteolytic degradation of extra-
cellular matrix by invading tumor cells.6,7 Thus, in line with
genome instability, pH gradient reversal could be considered as an
underlying cellular requirement for acquiring and maintaining
several other cancer traits during tumorigenesis. Yet, our
knowledge of its formation and maintenance is rather rudimen-
tary. Hitherto, plasma membrane-localized ion transporters,
including Na+/H+ exchanger 1 (NHE1), proton-linked monocar-
boxylate transporters and vacuolar H+-ATPase (V-ATPase), as well
as carbonic anhydrases, have been identiﬁed as proteins
contributing to the cancer-associated increase in net acid
extrusion.3 In addition to the acid removal via the plasma
membrane, V-ATPase pumps protons from the cytosol into
intracellular vesicles of the endo-lysosomal compartment, espe-
cially late endosomes and lysosomes, which serve as major
intracellular proton stores.8–10 For simplicity, we hereafter refer to
all organelles detected by ﬂuorescent dextran loading or staining
for V-ATPase subunits or lysosome-associated membrane proteins
LAMP1 or LAMP2 as lysosomes. Compared with normal cells, most
invasive cancer cells have an enlarged and highly acidic lysosomal
compartment, more peripherally localized lysosomes, and an
increase in lysosomal exocytosis.11–13 Thus, the lysosomal
V-ATPase may contribute to the establishment and maintenance
of the reversed pH gradient of cancer cells by removing cytosolic
protons to the lysosomal lumen, from where they can be
effectively discarded to the extracellular space via lysosomal
exocytosis.
V-ATPase is a large multi-subunit complex composed of 14
different proteins that are organized into a water soluble, ATP-
hydrolyzing V1 domain, and a membrane-embedded Vo proton
channel, which function together by coupling the energy of ATP
hydrolysis to the transport of protons across the lipid bilayer.8–10
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The V-ATPase-mediated acidiﬁcation of lysosomal lumen is
essential not only for the cargo degradation but also for the
cellular metabolism in general, e.g., through the regulation of
several key signaling pathways, including mechanistic target of
rapamycin complex 1 and Notch pathways.10,14 Furthermore,
V-ATPase activity has an important role in cancer cells by
enhancing their metastatic potential, chemotherapy resistance,
and survival in the acidic tumor environment.15–17
Signal transducer and activator of transcription-3 (STAT3) was
originally identiﬁed as a latent cytosolic transcription factor, which
could be activated by interferons and related cytokines to drive
the expression of acute phase genes regulating inﬂammation and
immunity.18 Today, STAT3 is known as a pleiotropic transcription
factor that is commonly activated in various cancers, where it can
act as an oncogene by activating genes involved in differentiation,
proliferation, apoptosis, metastasis, angiogenesis, and metabo-
lism.19–22 It is a member of STAT protein family that consists of
seven structurally related members in mammals.23,24 Akin to other
STATs, STAT3 contains six well-deﬁned structural domains as
follows: NH2-terminal domain, coiled-coil domain, DNA-binding
domain, linker domain, Src homology 2 (SH2) domain, and
transcriptional activation domain.25,26 Its transcriptional activity
depends on the phosphorylation of Tyr705 in the transcriptional
activation domain. Phosphorylated STAT3 can form homodimers
or heterodimers with other STAT proteins via reciprocal SH2-
phosphotyrosine interactions and translocate into the nucleus to
activate gene transcription. In normal cells, the transcriptional
activation occurs rapidly in response to cytokine signaling and is
transient, whereas oncogenes with tyrosine kinase activity, e.g.,
c-Src and activated members of epidermal growth factor receptor
family, keep STAT3 constitutively active in many cancers.27–29 For
a long time, it has been assumed that STAT3-mediated promotion
of tumor growth depends entirely on its well-described transcrip-
tional activities. STAT3 has, however, been demonstrated to
control cell metabolism and migration in a transcription-
independent manner. A small pool of acetylated and Ser727-
phosphorylated STAT3 is localized to mitochondria, where it may
promote malignant transformation and cancer progression by
supporting the optimal function of mitochondrial electron
transport chain and inhibiting the production of reactive oxygen
species.30–32 Furthermore, association of cytoplasmic STAT3 with a
mictotublule-destabilizing protein stathmin potentiates microtu-
bule polymerization and cell movement.33 Thus, transcriptional
and cytoplasmic activities of STAT3 may function in concert to
promote tumorigenesis.
Inspired by our ﬁnding of lysosome-associated STAT3, we
investigated its role in intracellular pH regulation. Here
we demonstrate that STAT3 associates with the lysosomal
V-ATPase complex, stimulates its ATPase activity, and contributes
to the maintenance of the alkaline cytosol and acidic lysosomal
lumen.
RESULTS
STAT3 localizes to the lysosomal membrane
Prompted by the punctate lysosome-like pattern of RFP-STAT3 in
live A549 non-small cell lung cancer cells, in which the NH2
terminus of the endogenous STAT3 gene is tagged with a red
ﬂuorescent protein (RFP) using transcription activator-like effector
nuclease-mediated knock-in,34 we investigated the putative
lysosomal localization and function of STAT3. For this purpose,
we took advantage of the above-mentioned A549-RFP-STAT3 cells
and conﬁrmed that in addition to a diffuse cytoplasmic localiza-
tion, RFP-tagged endogenous STAT3 formed numerous cytoplas-
mic puncta in untreated cells (Fig. 1a). Labeling the organelles of
A549-RFP-STAT3 cells with appropriate ﬂuorescent markers
revealed that the majority of the RFP-STAT3 puncta colocalized
with lysosomes labeled with cascade blue dextran or blue
ﬂuorescent protein (BFP) fused to either LAMP1 or LAMP2,
whereas no signiﬁcant colocalization was observed between
RFP-STAT3 puncta and markers of mitochondria, early endosomes,
or Golgi apparatus (Fig. 1a). The marker for endoplasmatic
reticulum stained large parts of the cytoplasm and therefore the
resolution of confocal microscopy did not allow a proper analysis
of its colocalization with RFP-STAT3 (Fig. 1a). To test whether
endogenous STAT3 localized to lysosomes in other cell types, we
generated SKOV3 ovarian carcinoma cells with enhanced green
ﬂuorescent protein (EGFP) fused to the NH2 terminus of the
endogenous STAT3 gene using CRISPR-Cas9 gene editing. Akin to
A549 cells, EGFP-tagged endogenous STAT3 formed cytoplasmic
puncta that colocalized with lysosomes in live SKOV3 cells
(Supplementary information, Fig. S1a). Notably, the punctate
pattern and lysosomal localization of STAT3 in A549-RFP-STAT3
and SKOV3-EGFP-STAT3 cells was largely abolished by treatments
commonly used to permeabilize ﬁxed cells for immunocytochem-
istry, i.e., methanol, saponin and triton (Supplementary informa-
tion, Fig. S1b and data not shown), which may explain why the
abundant lysosomal localization of STAT3 has not been discovered
earlier. Accordingly, co-staining of the endogenous, non-tagged
STAT3 and ATP6V01D, a lysosomally localized subunit of V-ATPase,
in ﬁxed and saponin-permeabilized HeLa cervix cancer cells
showed less colocalization of STAT3 and lysosomes than observed
by live-cell imaging (Supplementary information, Fig. S1c). Con-
ﬁrming its association with HeLa cell lysosomes, ∼5% of total
cellular STAT3 protein associated with lysosomes immunopuriﬁed
with antibodies against the cytosolic tail of LAMP1 or captured
with a magnet after iron-dextran loading of the lysosomal
compartment (Fig. 1b, c).
Although the nuclear and mitochondrial localizations of STAT3
depend on the phosphorylation of Tyr705 and Ser727, respec-
tively, the phosphorylation status of these sites in lysosomal STAT3
did not show clear preference to either modiﬁcation (Fig. 1b, c). To
ﬁnd out on which side of the lysosomal membrane STAT3 resided,
we exposed intact lysosomes to proteinase K in the presence or
the absence of a digitonin detergent. Unlike luminal cathepsin
D protein, which was effectively digested by proteinase K only in
the presence of detergent, STAT3 was completely digested in the
absence of detergent (Fig. 1d). These data suggest that STAT3
resides on the cytosolic surface of the lysosomal membrane and
should therefore be able to be mobilized by an appropriate
stimulus. Correspondingly, treatment of A549-RFP-STAT3 cells
with interleukin 6, a potent inducer of nuclear localization and
transcriptional activity of STAT3,35 triggered a rapid decline in
cytoplasmic STAT3-positive puncta and a simultaneous accumula-
tion of STAT3 in nuclei (Fig. 1e). Taken together, these data
suggest that in the absence of activating stimuli, a fraction of
cellular STAT3 is loosely attached to the cytosolic side of lysosomal
limiting membrane.
STAT3 interacts with V-ATPase on the lysosomal membrane via its
coiled-coil domain
To understand the putative function of lysosomal STAT3,
we searched for STAT3-interacting proteins in lysosomal extracts
of HeLa cells transiently transfected with Flag-tagged STAT3
(STAT3-Flag). Nanoscale-liquid chromatography tandem mass
spectrometry (nano-LC-MS/MS) analysis of proteins co-
immunoprecipitating with STAT3-Flag identiﬁed eight subunits
of the V-ATPase complex as potential STAT3-binding partners
(Fig. 2a). As described above, V-ATPase is a large multi-subunit
complex composed of a cytosolic ATP-hydrolyzing V1 domain and
a membrane-embedded Vo proton channel.
8 Of the eight
V-ATPase subunits identiﬁed as putative STAT3-associating
proteins, one was a Vo subunit (ATP6V0D1) and seven were
V1 subunits, and ATP6V1A was the strongest candidate based on
the amount of protein co-immunoprecipitating with STAT3-Flag,
the number of peptides identiﬁed, and repeated identiﬁcation in
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independent experiments (Fig. 2a). Similar association of endo-
genous STAT3 with the V-ATPase complex was demonstrated by
its ability to co-precipitate with endogenous ATP6V1A as analyzed
by immunoblotting and nano-LC-MS/MS (Fig. 2b; Supplementary
information, Fig. S2a and b), and to co-precipitate with the V-
ATPase complex puriﬁed with hemagglutinin-tagged ATP6V1A
(Fig. 2c). Super resolution-structured illumination microscopy
(SR-SIM) conﬁrmed the close proximity of endogenous STAT3
and ATP6V0D1 in intact HeLa cells (Fig. 2d, e). Likewise, proximity
ligation assay (PLA), which detects protein colocalization with
single-molecule resolution, gave strong, punctate PLA signals for
STAT3 and ATPV6A1 in HeLa cells, as well as in non-transformed
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pancreatic duct epithelial cells (H6C7) and mammary ﬁbroblasts
(HMF3), but not in their STAT3-depleted counterparts (Fig. 2f, g).
Notably, PLA for STAT3 and other abundant lysosomal membrane
proteins LAMP1 and CD63 gave practically no signal (Fig. 2h).
To characterize the association between STAT3 and the
V-ATPase complex, we performed mutagenesis of STAT3 and
investigated the ability of the Flag-tagged STAT3 mutants to
associate with the V-ATPase complex by PLA employing
antibodies against Flag and ATP6V1A in HeLa cells. The ﬁrst 138
amino acids of the NH2 terminus of STAT3 failed to colocalize with
ATP6V1A, whereas NH2-terminal STAT3 fragments of 321 or 688
amino acids showed roughly similar colocalization to the wild-type
protein (Fig. 3a, b; Supplementary information, Fig. S3a). Thus, the
coiled-coil domain residing between the amino acids 138 and 321
appeared to be essential for the interaction. To corroborate this
hypothesis, we deleted a highly conserved sequence between
residues 239 and 280 of the STAT3 coiled-coil domain (Supple-
mentary information, Fig. S3a). The obtained coiled-coil mutant
(CCM) failed to associate with ATP6V1A in spite of its relatively
high expression in HeLa cells (Fig. 3b and Supplementary
information, Fig. S3b). On the contrary, mutants lacking the entire
DNA-binding domain (ΔDB) or SH2 domain (ΔSH2), as well as
single amino acid mutants defective in mitochondrial (Ser727Ala;
S727A) or transcriptional (Tyr705Phe; Y705F) functions of STAT3
colocalized with ATPV1A approximately as well as or even better
than the wild-type protein (Fig. 3b). Notably, cells expressing
STAT3-Y705F-Flag mutant showed a similar PLA signal to cells
expressing the wild-type STAT3-Flag in spite of ∼10-fold higher
expression level of the latter (Fig. 3b and Supplementary
information, Fig. S3b). Correspondingly, immunoblot analyses of
subcellular fractions of HeLa cells expressing STAT3-Y705F-Flag
revealed almost exclusively lysosomal localization of this mutant
(Fig. 3c). These data strongly suggest that the coiled-coil domain
of STAT3 associates with the V-ATPase complex, and that this
association does not require phosphorylation of Tyr705 or Ser727
residues.
STAT3 enhances lysosomal acidiﬁcation and activity
Prompted by the association of STAT3 with the V-ATPase complex,
we investigated whether STAT3 regulated the activity of the
V-ATPase. For this purpose, we depleted STAT3 from HeLa cells
using CRISPR-Cas9-mediated gene editing and estimated lysoso-
mal pH based on the ﬂuorescence intensity ratio of pH-sensitive
ﬂuorescein (FITC) and pH-insensitive tetramethylrodamine (TMR)
in cells loaded with dextran coupled to these dyes.36 The
estimated lysosomal pH values in STAT3-deﬁcient HeLa clones
were increased from the 4.6 in control cells to 5.3 and 5.6 in
STAT3-KO-1 and STAT3-KO-11 clones, respectively (Fig. 4a and
Supplementary information, Fig. S4a). In non-transformed HMF3
mammary ﬁbroblasts and H6C7 pancreatic duct epithelial cells,
CRISPR-Cas9-mediated STAT3 depletion increased the lysosomal
pH signiﬁcantly, albeit to a lesser extent than in HeLa cells (Fig. 4b
and Supplementary information, Fig. S4a). The increased lysoso-
mal pH in HeLa-STAT3-KO-11 clone was partially reverted in stable
clones reconstituted with wild-type STAT3 (Fig. 4a). Reconstitution
with Y705F, DNA-binding defective and S727A mutants of STAT3
resulted in a similar or even better rescue than wild-type STAT3 in
spite of their lower expression levels (Fig. 4a). As we did not obtain
stable clones expressing STAT3-CCM, the mutant that failed to
colocalize with the V-ATPase as analyzed by PLA (Fig. 3b), we
investigated its ability to rescue the lysosomal pH phenotype of
HeLa-STAT3-KO-11 cells after transient transfection. Contrary to
the wild-type STAT3, which signiﬁcantly reduced the lysosomal
FITC/TMR ratio following a transient transfection, STAT3-CCM
failed to do so (Supplementary information, Fig. S4b). To validate
the role of STAT3 in the acidiﬁcation of the lysosomal compart-
ment, we measured the volume of the acidic compartment of
HeLa cells loaded with Lysotracker Green by ﬂow cytometry. In
line with increased lysosomal pH observed by FITC/TMR ratio
measurements in HeLa-STAT3-KO clones, the STAT3-depleted cells
had a signiﬁcantly lower capacity to accumulate Lysotracker Green
than the control cells, and this phenotype was effectively rescued
by the reconstitution with the wild-type STAT3 or its Y705F, S727A,
and DNA-binding defective mutants (Fig. 4c; Supplementary
information, Fig. S4c and d). Further supporting the role of STAT3
in the acidiﬁcation of lysosomes, HeLa-STAT3-KO cells had
reduced maturation of cathepsin B (CTSB) and longer half-life of
lysosomal dextran conjugated to pH-insensitive AlexaFluor 488
(Fig. 4d, e).
STAT3 stimulates V-ATPase-mediated hydrolysis of ATP
The ability of Y705F and DNA -binding defective mutants of STAT3
to effectively rescue the lysosomal pH phenotype in STAT3-KO
cells strongly suggested that STAT3 acidiﬁes lysosomes indepen-
dently of its transcriptional activity. To substantiate this hypoth-
esis, we sequenced the transcriptomes of HeLa-C4 and HeLa-
STAT3-KO cells and compared the expression levels of mRNAs for
lysosomal proteins (Supplementary information, Fig. S5a and b).
STAT3 depletion did not reduce the expression of mRNAs for
major V-ATPase subunits (Supplementary information, Fig. S5a).
On the contrary, several of them and their corresponding proteins
(e.g., ATPV1A, ATPV1B2, and ATP6V0D1) were upregulated in
STAT3-KO cells (Fig. 5a and Supplementary information, Fig. S5a).
Out of all the genes whose protein products according to Gene
Ontology (www.geneontology.org/page/go-enrichment-analysis)
or Kyoto Encyclopedia of Genes and Genomes (www.genome.jp/
kegg/pathway.html) datasets localize to lysosomes, only 13 and
10 genes had over 1.5-fold reduced and increased expression,
respectively, in HeLa-STAT3-KO cells as compared with control
cells (Fig. 5b and Supplementary information, Fig. S5b). To our
knowledge, none of the altered genes, except for the upregulated
V-ATPase subunits, have been reported to regulate lysosomal pH.
These data suggest that STAT3 stimulates lysosomal acidiﬁcation
by a posttranscriptional mechanism. Thus, we tested whether
Fig. 1 STAT3 localizes to the lysosomal membrane. a Representative images of A549-RFP-STAT3 cells labeled with the indicated organelle
markers (blue). Values, mean percentage of RFP-STAT3 puncta colocalizing with the indicated organelle marker ± SD of three independent
experiments with ≥ 10 cells/sample analyzed in each. Colocalization analysis was not applicable (NA) in KDEL-BFP-labeled cells due to the
diffuse staining. The areas marked with white squares are magniﬁed in upper right corners. Images of live cells were taken with 60×
magniﬁcation using Zeiss LSM700 confocal microscope. See Supplementary information, Fig. S1 for colocalization of STAT3 and lysosomes in
other cells. b Representative immunoblots of STAT3 and the indicated organelle markers in total cell lysates or the indicated ﬂow throughs
(FT) and immunoprecipitates (eluate) from HeLa cells. n= 3. c Representative immunoblots of the indicated proteins in total cell lysates or the
indicated fractions of HeLa cells (left) and quantiﬁcation of P-Y705-STAT3 and P-S727-STAT3 levels relative to total STAT3. d Representative
immunoblots (top) and quantiﬁcation (bottom) of the indicated proteins in lysates of HeLa cell lysosomes puriﬁed by iron-dextran method
and left untreated or treated with 10 µg/ml proteinase K and 100 µg/ml digitonin for 10min at 25 °C when indicated. CTSD, cathepsin D.
e Representative images (left) and quantiﬁcation of cytosolic RFP-STAT3 puncta (right) in A549-RFP-STAT3 cells left untreated or treated with
100 ng/mL IL6 for 30min and stained with Hoechst. Error bars, SD of three independent experiments, with ≥ 10 cells analyzed/sample.
P- values were calculated by one-way ANOVA combined with Dunnett’s multiple comparisons test (c) or two-tailed, homoscedastic Student’s
t-test (e). The optimal slice thickness (∼350 nm) of confocal images (a, e) was deﬁned by the Zeiss zen software. Scale bar, 10 µm
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STAT3 regulated the assembly of V1 and Vo domains of the V-
ATPase complex by investigating their proximity by PLA employ-
ing antibodies against ATPV1A and ATP6V0D1. The PLA was
validated by the efﬁcient reduction in the number of PLA puncta
upon small interfering RNA (siRNA)-mediated depletion of either
ATPV1A or ATP6V0D1 (Fig. 5c, d). HeLa-STAT3-KO-11 cells had as
many PLA puncta as the control cells, indicating that STAT3 does
not control the assembly of the V-ATPase complex (Fig. 5d). In line
with this, the signiﬁcant reduction in the colocalization of STAT3
with ATP6V1A and ATP6V0D1 following the siRNA-mediated
depletion of ATP6V0D1 and ATP6V1A, respectively, suggested
that STAT3 associates with the assembled V-ATPase complex
STAT3 regulates cellular pH equilibrium
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(Fig. 5c, e). Finally, the ability of STAT3 to directly enhance V-
ATPase activity was supported by in vitro reconstitution experi-
ments showing that recombinant STAT3 enhanced the baﬁlomy-
cin A1-sensitive ATPase activity of the immunopuriﬁed V-ATPase
complex (Fig. 5f). Taken together, these data suggest that STAT3
enhances lysosomal acidiﬁcation by stimulating the ATPase
activity of the V1 domain in the assembled V-ATPase complex
on the lysosomal membrane.
Cytosolic pH regulates STAT3 localization and STAT3 localization
regulates cytosolic pH
Inspired by the ability of STAT3 to enhance the V-ATPase-
mediated transfer of protons from the cytosol to lysosomes, we
tested whether its subcellular localization could be regulated by
changes in intracellular pH. To disrupt the intracellular pH
equilibrium, we starved cells for amino acids to enhance the
V-ATPase activity,37 or exposed them to ﬁve short (15–60min)
treatments that acidify the cytosol (Supplementary information,
Fig. S6a), i.e., (i) V-ATPase inhibitor baﬁlomycin A1,38 (ii) lysosomal
membrane destabilizer L-leucyl-L-leucine methyl ester (LLOMe),39
(iii) niclosamide, a protonophore that carries protons across
membranes,40 or (iv) ethylisopropyl amiloride (EIPA), an inhibitor
of plasma membrane NHE1, in the absence of NaHCO3/CO2 buffer
system or (v) in the presence of propionic acid (propionate).41 All
tested treatments signiﬁcantly enhanced the association of RFP-
STAT3 with lysosomes in A549-RFP-STAT3 cells as demonstrated
by increased RFP-STAT3 puncta formation and signiﬁcantly
enhanced lysosomal ﬂuorescence intensity of RFP-STAT3 (Fig. 6a).
In HeLa cells, all tested treatments triggered a signiﬁcant increase
in lysosomal STAT3 as demonstrated by signiﬁcantly increased
STAT3/LAMP1 ratios in immunoblots of lysosomal lysates (Fig. 6b).
These increases were likely due to the translocation of STAT3 from
other cellular compartments, as none of the short treatments
induced detectable changes in the expression levels of STAT3 or
LAMP1 (Fig. 6b, c). In addition, all cytosol-acidifying treatments
effectively reduced the phosphorylation of Tyr705-STAT3 in HeLa
and A549 cells (Fig. 6c, d; Supplementary information, Fig. S6b). In
agreement with the dependence of the transcriptional activity of
STAT3 on P-Tyr705, cytosolic acidiﬁcation reduced the levels of
proteins encoded by known STAT3 target genes, CCND1 and
BIRC5, as analyzed by immunoblotting (Fig. 6d), CCND1 mRNA as
analyzed by quantitative PCR (qPCR) (Fig. 6e), and mRNA levels of
CCND1, MYC, and 179 other predicted STAT3 target genes as
analyzed by whole transcriptome sequencing (Supplementary
information, Fig. S6c). Thus, acidiﬁcation of the cytosol triggers a
rapid dephosphorylation of P-Tyr705-STAT3 accompanied by
translocation of STAT3 to the lysosomes, where it can promote
the neutralization of the acidic cytosol by enhancing the proton
pumping activity of the V-ATPase complex.
Most cancers depend on aerobic glycolysis to generate ATP,
and several oncogenes enhance this process by upregulating the
expression of glucose transporters and glycolytic enzymes.42 This
results in increased cytosolic lactate production. Thus, we tested
whether oncogene-mediated activation of glycolysis and sub-
sequent acid production are associated with enhanced transloca-
tion of STAT3 to the lysosomes. For this purpose, we used MCF7
cells with inducible expression of N-terminally truncated active
form of ErbB2 oncogene, p95ΔNErbB2,43 which enhances
glycolysis by upregulating lactate dehydrogenase expression.44,45
Immunopuriﬁed lysosomes from MCF7-p95ΔNErbB2 cells had
over ten times higher STAT3/LAMP1 ratio than control MCF7 cells,
whereas the level of total STAT3 was similar (Fig. 6f and
Supplementary information, Fig. S6d). Increased lysosomal
localization of STAT3 in MCF7-p95ΔNErbB2 cells was conﬁrmed
by PLA for STAT3 and ATP6V1A (Fig. 6g). Taken together, these
data suggest that the increased acid production in cancer cells
increases the amount of lysosomal STAT3, which in turn enhances
the proton pumping activity of the V-ATPase thereby possibly
assisting in the maintenance of alkaline cytosol in spite of
increased acid load.
STAT3 protects cells against cytosolic acidiﬁcation
As mentioned above, malignant transformation and cancer
progression depend on reverse pH gradient, and cancer cells
maintain higher cytosolic pH (pHc) than non-transformed cells.
3
Consistent with the role for STAT3 in the maintenance of alkaline
pHc of cancer cells, the pHc of both STAT3-KO clones was
signiﬁcantly lower (7.09 and 7.14) than the pHc of 7.54 in control
HeLa cells (Fig. 7a). The decreased pH in STAT3-KO cells was
effectively reverted by reconstitution with either the wild-type
STAT3 or its mainly lysosomal and transcriptionally defective
Y705F mutant (Fig. 7a). Moreover, both STAT3-KO clones died
signiﬁcantly more than control cells when exposed to stresses
affecting intracellular proton equilibrium, i.e., amino acid starva-
tion or cytosolic acidiﬁcation (Fig. 7b). Notably, the sensitivity to
cytosolic acidiﬁcation could be effectively rescued by the ectopic
expression of either the wild-type STAT3 or its Y705F mutant
(Figs. 3c and 7c). Thus, in response to cytosolic acidiﬁcation,
P-Tyr705-STAT3 is dephosphorylated and more STAT3 is recruited
to lysosomal membranes to enhance the V-ATPase activity and
cell survival, whereas the transcriptional activity of STAT3 is
inhibited.
Fig. 2 STAT3 interacts with V-ATPase on the lysosomal membrane. a V-ATPase subunits detected by high-accuracy mass spectrometry in anti-
Flag immunoprecipitates of lysosomal lysates from HeLa cells transiently transfected with pBCMV-STAT3-Flag-puro. Protein amount in relation
to STAT3 was estimated from summed peptide intensities (iBAQ algorithm in Maxquant software). The criteria for false discovery rate (FDR) of
peptide spectrum match was set to 0.05 and protein FDR to 0.01. Numbers of peptides with identiﬁcation P-values < 0.01 are indicated.
Experiment was repeated once with similar results. b Representative immunoblots of endogenous STAT3 and ATP6V1A (V1A) in anti-STAT3
immunoprecipitates (IP) and lysates of crude lysosome fractions of HeLa cells. n= 3. c Representative immunoblots of the indicated proteins
in anti-HA immunoprecipitates (IP) and lysates of crude lysosome fractions of HeLa cells transiently transfected with pCDNA3.1-HA-ATP6V1A.
n= 3. d A representative SR-SIM image of a HeLa cell stained with anti-STAT3 and anti-ATP6V0D1 antibodies. The areas marked with white
squares are magniﬁed in both sides. Scale bars, 5 µm (middle) and 200 nm (left and right). e Representative images of the indicated SR-SIM
projections (left) and colocalization analysis (right) of a punctum staining with anti-STAT3 and anti-ATP6V0D1 (V0D1) antibodies in HeLa cells.
Scale bars, 145 nm (yellow) and 200 nm (white). f Representative images (left) and quantiﬁcation (right) of PLA puncta with antibodies against
STAT3 and ATP6V1A in HeLa CRISPR control cell clone (C-4) and STAT3-KO clone (STAT3-KO-11). Lysosomes were visualized by loading with
cascade blue dextran. See Fig. 4a for the immunoblot verifying STAT3 depletion. g Representative images of PLAs using antibodies against
STAT3 and ATP6V1A in CRISPR control and STAT3-KO human pancreatic duct epithelial cells (H6C7) and human mammary ﬁbroblasts (HMF3)
counterstained with DAPI. See Supplementary information, Fig. S2c for the immunoblot verifying STAT3 depletion. h Representative images
(left) and quantiﬁcation (right) of PLA puncta with antibodies against STAT3 and LAMP1 or CD63 in HeLa-C-4 clone. Nuclei were
counterstained with DAPI. Cell images in f–h were taken with 60× magniﬁcation using Zeiss LSM700 confocal microscope. The optimal slice
thickness (∼350 nm) was deﬁned by the Zeiss zen software. The images of H6C7 cells in g are integrated stacks. Scale bar, 10 µm. Error bars, SD
of three independent experiments with ≥ 10 cells analyzed/sample. P-values were calculated by two-tailed, homoscedastic Student’s t-test
(f) or one-way ANOVA combined with Dunnett’s multiple comparisons test (h)
STAT3 regulates cellular pH equilibrium
B. Liu et al.
1001
Cell Research (2018) 28:996 – 1012
DISCUSSION
In addition to its canonical role as a nuclear transcription factor,
STAT3 is today recognized as a multifunctional protein that has
non-canonical roles both in nucleus and cytoplasm. The data
presented here reveal a previously unrecognized role for the
cytoplasmic STAT3 in the control of intracellular pH homeostasis
via its association with the lysosomal V-ATPase.
Mitochondrial STAT3 has received ample attention in recent
years,32 whereas the putative functions of STAT3 in other
cytoplasmic compartments have been largely ignored. Using
multiple state-of-the art methods, we demonstrate here a dynamic
colocalization of STAT3 with the lysosomal compartment. Live-cell
imaging of endogenous STAT3 fused to ﬂuorescent proteins and
immunocytochemistry employing anti-STAT3 antibodies revealed
predominantly punctate cytoplasmic STAT3 signals that coloca-
lized almost exclusively with lysosomal markers in A549, SKOV3
and HeLa cells. Furthermore, STAT3 co-precipitated with meticu-
lously puriﬁed lysosomal fractions of HeLa cells that were devoid
of detectable amounts of protein markers for other cellular
compartments. Contrary to the predominantly lysosomal localiza-
tion of STAT3 puncta observed by imaging, only ∼5% of the total
STAT3 co-puriﬁed with the lysosomes of cells growing in normal
culture conditions. This discrepancy could be due to a high local
concentration of STAT3 in individual lysosomes resulting in
intensive local ﬂuorescence or dissociation of the loosely attached
STAT3 from the lysosomes during the organelle puriﬁcation.
Punctate cytoplasmic STAT3 staining pattern has been pre-
viously reported in cells treated with cytokines or growth factors.
During receptor-mediated endocytosis, Tyr705-phospshorylated
STAT3 colocalizes with endocytic vesicles in transit from the cell
membrane to the perinuclear region.46–48 In pulmonary arterial
hypertension, this centripetal trafﬁcking of STAT3 is disturbed in
pulmonary arterial cells, where STAT3 and P-Tyr705-STAT3 are
sequestered inside the lysosomes.49 In our experiments employ-
ing untreated cancer cells, STAT3 did not colocalize with early
endosomes, and the majority of lysosomal STAT3 was not
phosphorylated at Tyr705 residue. Furthermore, and contrary to
the lysosomal localization of STAT3 induced by pulmonary arterial
hypertension, STAT3 resided on the cytosolic side of the lysosomal
membrane in normally growing cancer cells. Therefore, this
lysosomal pool of STAT3 appears to be distinct from the pool of
STAT3 previously detected in the endo-lysosomal compartment. It
should be noted that the lysosomal localization of STAT3 was not
limited to the three cancer cell lines mentioned above, but was
also observed in non-transformed human mammary ﬁbroblasts
and pancreatic duct epithelial cells. Therefore, it is surprising that
except for two proteomics datasets that list STAT3 as a lysosomal
protein,50,51 the apparently widespread association of STAT3 with
the lysosomal outer membrane has not been reported earlier. This
may be due to its very loose and dynamic association with the
lysosomes that is easily disturbed even by mild detergents
commonly used to permabilize cells for immunocytochemistry or
immunoprecipitation. In line with this, the dynamic lysosomal
localizations of several signaling complexes, e.g., the intensively
studied mammalian target of rapamycin complex 1 and AMP-
activated protein complex, were discovered relatively late, while
having been missed by most studies intending to reveal the
lysosomal proteome.52–54
Further supporting the existence of STAT3 on lysosomal
membranes, we identiﬁed an association between the V-ATPase
complex and an evolutionarily highly conserved sequence in the
coiled-coil domain of STAT3. In repeated experiments, both
endogenous and exogenous STAT3 co-precipitated with various
V-ATPase subunits, and the catalytic ATP6V1A subunit of the
cytoplasmic V1 domain was the most abundant and most
frequently identiﬁed binding partner. As the V1 complex does
not form in the absence of ATP6V1A subunit and since the
individual subunits of the V1 and Vo complex are poorly soluble
Fig. 3 STAT3 interacts with V-ATPase via its coiled-coil domain.
a Domain structure of STAT3 with mutations used in b indicated
below. SH2, Src homology 2 domain; TAD, transactivation domain.
b Quantiﬁcation of PLA (anti-Flag and anti-ATP6V1A) puncta in HeLa
cells expressing the indicated Flag-tagged STAT3 constructs (top).
Error bars, SD of three independent experiments with ≥ 10 cells
analyzed/sample. P-values were calculated by one-way ANOVA
combined with Dunnett’s multiple comparisons test. Rough
estimates of the relative expression levels of Flag-tagged STAT3
constructs are shown below the histogram as percentages of the
expression of the wild-type STAT3. See Supplementary information,
Fig. S3b for representative immunoblots. Bottom, representative
images of PLAs taken with 60× magniﬁcation using Zeiss LSM700
confocal microscope. The optimal slice thickness (∼350 nm) was
deﬁned by the Zeiss zen software. Lysosomes were visualized with
cascade blue dextran. Scale bar, 10 µm. c Representative immuno-
blots of the indicated proteins in total cell lysates or the indicated
fractions of HeLa-STAT3-KO cells reconstituted with STAT3-Y705F (20
µg protein/lane). n= 3
STAT3 regulates cellular pH equilibrium
B. Liu et al.
1002
Cell Research (2018) 28:996 – 1012
when not in complex with the other subunits (K.M., unpublished
data), we were not able to verify the direct association between
STAT3 and ATP6V1A in vitro. The signiﬁcant reduction of the PLA
signal from ATPV0D1 and STAT3 upon depletion of the ATP6V1A
subunit supported, however, the idea that STAT3 associated with
V-ATPase via the ATP-hydrolyzing V1 complex. This was further
substantiated by the ability of STAT3 to enhance the ATPase
activity of the V-ATPase complex in vitro. The characterization of
the molecular details of this association will require extensive
structural analyses of the entire membrane-embedded V-ATPase
complex, which are out of the scope of this study.
The V-ATPase controls lysosomal luminal pH in tightly regulated
manner that promptly responds to extracellular and intracellular
cues.9 This requires constant and precise control of the speed of
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proton pumping, which is achieved by ﬁne-tuning the activity and
density of the V-ATPase. The molecular mechanisms underlying
this regulation are only beginning to emerge. The proton
pumping activity of the V-ATPase is rapidly and effectively
controlled by the assembly status of the V1 and Vo domains,
55
and in a slower fashion by the relative expression levels of the
V-ATPase subunits,56 whereas the density is determined mainly by
the expression levels of the subunits and various membrane
fusion and ﬁssion events.57 Here, we introduce STAT3 as a potent
regulator of intracellular pH, whose depletion results in signiﬁcant
increase in lysosomal pH and decrease in cytosolic pH, respec-
tively. We propose that STAT3 enhances the ATPase activity of the
cytosolic V1 complex via a direct association with the complex or a
regulatory protein tightly associated with it. This hypothesis is
based on the ability of recombinant STAT3 to promote the
baﬁlomycin A1-sensitive ATPase activity of the V-ATPase complex
in a reconstitution assay in vitro, as well as by meticulous
exclusion of alternative possibilities. It is highly unlikely that the
STAT3-mediated intracellular pH regulation is mediated by its
canonical or non-canonical transcription-regulating functions.
First, the pH phenotype of STAT3-depleted cells was effectively
rescued not only by the wild-type STAT3 but also by STAT3
mutants (Y705F, ΔSH2, and DNA-binding mutants) unable to
activate the transcription of classical STAT3 target genes. Second,
STAT3 depletion reduced neither the protein expression of major
V-ATPase subunits nor mRNA levels of any genes encoding
V-ATPase subunits or other proteins reported to regulate
lysosomal pH, e.g., lysosomal members of the chloride channel
or transient receptor potential channel families or known
regulators of the V-ATPase assembly. Third, a recent proteomics
study on the STAT3-mediated regulation of lysosomal composi-
tion did not identify STAT3 dependancy for any known pH
regulating lysosomal proteins.58 Finally, genes encoding such
proteins were not identiﬁed as non-canonical transcriptional
targets of STAT3, which can be activated in the absence of
Tyr705 phosphorylation.59 As STAT3 depletion failed to reduce the
assembly of V1 and Vo domains as demonstrated by unaltered
proximity of ATP6V1A and ATP6V0D1 in STAT3-depleted cells, it is
also unlikely that STAT3-mediated regulation of intracellular pH
involves the association of the two domains. In light of these data,
the most probable explanation is that STAT3 directly regulates the
activity of the V-ATPase. Interestingly, a change in the luminal pH
of the lysosomes has been suggested to induce a change in the
V-ATPase conformation, which facilitates its binding to Arf6
nucleotide-exchange factor thereby regulating endosome recy-
cling.60 Thus, it is tempting to speculate that similar pH-regulated
conformational changes in either the V-ATPase or STAT3 could
regulate the association of STAT3 and the V-ATPase complex to
assist in the reestablishment of the intracellular pH homeostasis.
The putative relevance of such local STAT3-mediated regulation of
the V-ATPase activity is supported by our data showing that the
neutralization of the lysosomal lumen and/or acidiﬁcation of the
cytosol can increase the recruitment of STAT3 to the lysosomal
membrane up to tenfold in only 30min. In this manner, STAT3 can
rapidly respond to disturbances of intracellular pH equilibrium by
enhancing the rate of proton exclusion from the cytosol to the
lysosomal lumen and thereby enhance the survival of cells upon
increased acid load. In line with this, STAT3 depletion sensitized
cells to cell death induced by cytosolic acidiﬁcation and this
phenotype was effectively reverted by wild-type STAT3 as well as
its Y705F mutant. Even though the lysosomal compartment may
have a limited capacity to receive protons from the considerably
larger volume of the cytosol, this process combined with removal
of lysosomal protons to the extracellular space via lysosomal
exocytosis could be an effective way of retaining alkaline cytosol
even during long-lasting acidifying stress caused, e.g., by
increased glycolysis in cancer cells. Hence, STAT3 may enhance
cancer cell survival by augmenting the adaptation of the cells to
the acidic tumor environment and increased acid production.
In conclusion, we have identiﬁed an intriguing feedback loop
between cytosolic pH and STAT3 that contributes to the
maintenance of alkaline pHc, acidiﬁcation of lysosomes and
transcriptional activity of STAT3 in cancer cells (Supplementary
information, Fig. S7). In spite of the critical role of STAT3 in human
malignancies and decades of intensive research aiming at the
development of drugs interfering with STAT3 activity, there are no
clinically approved drugs directly targeting STAT3 so far. One
possible explanation is that most efforts have focused on the
inhibition of the STAT3’s nuclear function, which may indirectly
result in an increase in its extranuclear activities, i.e., regulation of
mitochondrial electron transfer chain as suggested earlier,30,31 and
maintenance of alkaline pHc and lysosomal function as proposed
here. The identiﬁcation of these non-transcriptional roles of STAT3
will hopefully inspire further studies that can result in more holistic
strategies to target STAT3 in cancer treatment.
MATERIALS AND METHODS
Reagents and resources
Sources of reagents and resources used are listed in Supplemen-
tary information, Table S1.
Cell culture
Human A549 non-small cell lung carcinoma (male), HeLa cervix
carcinoma, and SKOV3 ovarian carcinoma were obtained from
American Type Culture Collection (ATCC). The cells were
authenticated by ATCC and used within 6 months after thawing.
Human pancreatic duct epithelial cells (H6C7) were purchased
from Kerafast. Human immortalized mammary ﬁbroblasts (HMF3)
were kindly provided by Michael J. O’Hare (Ludwig Institute for
Cancer Research, London, UK).61 Lenti-XTM 293T human embryonic
kidney epithelial cells transformed with Adenovirus type 5 DNA
were from Clontech (632180). A549-triple cells (here referred to as
A549-RFP-STAT3 cells) were kindly provided by Dmitry Malkov
Fig. 4 STAT3 regulates lysosomal pH and activity. a Lysosomal pH determined by FITC/TMR ratio in a HeLa CRISPR control cell clone (C-4),
STAT3-KO clones (KO-1 and −11), and KO-11 clone reconstituted with wild-type (WT) or mutated (Y705F, DBM, S727A) STAT3 constructs.
Representative immunoblots show STAT3 and ACTB (loading control) protein levels in the clones. Standard curve for pH measurements is
shown in Supplementary information, Fig. S4a. b Lysosomal pH determined as in a in CRISPR control and STAT3-KO HMF3 and H6C7 cells.
Standard curve for pH measurements is shown in Supplementary information, Fig. S4a. c Volume of acidic compartment (VAC) in HeLa cell
clones described in a analyzed by ﬂow cytometer after 5 min staining with 75 nM Lysotracker Green. Relative ﬂuorescence intensities are
shown on the left. A representative ﬂow cytometry proﬁle is shown on the right. For other ﬂow cytometry proﬁles and gating of the cells, see
Supplementary information, Fig. S4c and d. d Representative immunoblots of LAMP1, STAT3, and cathepsin B (CTSB) in lysosomal lysates of
the indicated HeLa cell clones. The histogram shows ratios between the active (25 kDa) and inactive (31 kDa) CTSB as percentages of the value
in C4 control clone. e AlexaFluor 488-Dextran degradation in the indicated HeLa clones loaded with 0.4 mg/ml AlexaFluor 488-dextran for
20min, washed, and ﬁxed with or without a 4 h chase period. Representative images taken with 60× magniﬁcation using Zeiss LSM700
confocal microscope are shown on the right. Error bars, SD of ≥ 3 independent experiments. A minimum of 10 cells/sample were analyzed in
a, b, and e. P-values were calculated by one-way ANOVA combined with Dunnett’s multiple comparisons test (a, c) or two-stage linear step-up
procedure of Benjamini, Krieger, and Yekutieli (b, d) for multiple comparisons, or by two-tailed, homoscedastic Student’s t-test (e)
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(Sigma-Aldrich, St. Louis, Missouri, USA).34 Human MCF7 mammary
carcinoma cells stably transfected with inducible pTRE-p95ErbB2
or corresponding pTRE vector were established and cultured as
described previously.13,43 The expression of p95ErbB2 was
induced by washing off the tetracycline (1 µg/ml) three passages
before the experiment. H6C7 cells were cultured in serum free
media (SFM). Other cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10% heat-inactivated
fetal calf serum and penicillin/streptomycin (complete medium),
and for H6C7 cells also with 2 mM glutamine. Cells were
maintained at 37 °C and 5% CO2. All cell lines were found
negative for mycoplasma using Venor®GeM Classic PCR kit.
Fig. 5 STAT3 enhances V-ATPase activity. a Representative immunoblots (left) and quantiﬁcation (right) of the indicated V-ATPase subunits
from lysates of HeLa CRISPR control clone (C-4) and STAT3-KO clones (KO-1 and −11). TUBA1A served as a loading control. b Numbers of
lysosomal genes whose expression analyzed by RNA-Seq was decreased or increased over ≥ 1.5-fold (P ≤ 0.05) in HeLa-STAT3-KO cells as
compared to HeLa-C4 control cells. Lysosomal genes were deﬁned as genes whose protein products localize to lysosomes according to either
Gene Ontology or Kyoto Encyclopedia of Genes and Genomes databases. See Supplementary information, Fig. S5b for the list of altered
genes. c Representative immunoblots of the indicted proteins from lysates of HeLa cells transfected with the indicated siRNAs 72 h earlier. n=
3. d Representative images (left) and quantiﬁcation (right) of PLA puncta with antibodies against ATP6V1A (V1A) and ATP6V0D1 (V0D1) in
HeLa CRISPR control (C-4) and STAT3-KO (STAT3-KO-11) cells, as well as in HeLa cells transfected with the indicated siRNAs 72 h earlier. DNA
was stained with DAPI. Images were taken with 60×magniﬁcation using Zeiss LSM700 confocal microscope. The optimal slice thickness (∼350
nm) was deﬁned by the Zeiss zen software. Scale bar, 10 µm. e Quantiﬁcation of PLA puncta with antibodies against STAT3 and V1A in HeLa
cells (left) or Flag and V0D1 in HeLa-STAT3-Flag cells (right). Cells were transfected with the indicated siRNAs 72 h earlier. f Activity of V-ATPase
in the presence of 30 µg/mL superfolder-GFP (sfGFP; control) or ΔN-STAT3-sfGFP. V-ATPase was immunoprecipitated with anti-HA magnetic
beads from lysosomal lysates of HeLa cells transiently transfected with pCDNA3.1-HA-ATP6V1A. When indicated, the samples were treated
with 100 nM baﬁlomycin A1. Right, standard curve for the measurement of the free phosphate ion used to estimate the ATP consumption.
Protein blot for recombinant proteins is shown in Supplementary information, Fig. S5c. Error bars, SD of ≥ 3 independent experiments.
A minimum of ten cells/sample were analyzed in d, e. P-values were calculated by one-way ANOVA combined with Dunnett’s multiple
comparisons test (a, d), DEseq2 (b), or by two-tailed, homoscedastic Student’s t-test (e, f)
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STAT3 mutagenesis
To perform site-directed mutagenesis of STAT3, pCDNA3.1-DYK-
STAT3 was PCR ampliﬁed using KOD Xtreme™ Hot Start DNA
Polymerase and primers listed in Supplementary information,
Table S2. Larger deletions (ΔDB and ΔSH2) were performed as
described previously,62 using primers listed in Supplementary
information, Table S2. Ampliﬁed DNA digested with DpnI was
ampliﬁed in Escherichia coli DH5α. The obtained sequence-veriﬁed
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plasmids and EF.STAT3-Y705F.Ubc.GFP63 were used as templates
for the construction of STAT3 expression plasmids described in
Supplementary information, Table S3.
Transfections
If not otherwise stated, transfections were performed using
TurboFectin 8.0 or Lipofectamine 3000 transfection agents
according to the manufacturer’s instructions.
siRNAs were transfected with Lipofectamine RNAmax at 20 nM
according to the manufacturer’s protocol and cells were analyzed
72 h later.
To create stable cell lines, lentiviral and packaging plasmids
were transfected into subconﬂuent Lenti-XTM 293T cells. After
48 h, virus particles were collected with PEG-it™ Virus Precipitation
Solution according to the manufacturer’s instructions. HeLa cells
growing on six-well plates (2 × 105 cells/well) were treated with
5 µl of the obtained virus suspension supplemented with 8 µg/mL
protamine sulfate and spin-infected by centrifugation at 2,400× g
for 90 min. After 48 h, cells were transferred to 10 cm petri
dish and the medium was supplemented with 200 µg/mL
hygromycin B. After ~3 weeks of selection, stable clones were
picked and analyzed by immunoblotting to identify successfully
transfected clones.
For transposon-mediated transfection, expression plasmids and
super transposase vector (1:1) were co-transfected into HeLa cells
growing on six-well plates (2 × 105 cells/well). After 48 h, cells were
transferred into a 10 cm petri dish and the medium was
supplemented with 1 µg/mL puromycin. After ~2 weeks of selection,
stable clones were picked and validated by immunoblotting.
CRISPR/Cas9-mediated gene editing
STAT3-knockout cells were generated using CRISPR/Cas9-
mediated gene editing essentially as described previously.64
Single-guide RNA targeting STAT3 was created by cloning
appropriate primers into pxpr00165 and transfected to HeLa,
H6C7, or HMF3 cells. After 2 weeks of selection in medium
containing 1 µg/mL puromycin, clones were picked up and
validated by immunoblotting and sequencing.
The EGFP-STAT3 tagging CRISPR gRNA was generated by
cloning the guide sequences Cr-Uni and Cr-STAT3 into the pMA-
SpCas9-g1 and pMA-SpCas9-g2 gRNA expression vectors, respec-
tively.66 The pAAV-EGFP-MMEJ vector was generated by amplify-
ing the EGFP coding sequences from ptfLC3 (kindly provided by
Dr. Yoshimori67) with speciﬁc primers listed in Supplementary
information, Table S3. The PCR product was digested by NotI and
ligated into a pAAV-MCS vector. All plasmids were further
validated by Sanger sequencing.
To generate the SKOV3-EGFP-STAT3 cells, SKOV3 cells growing
on six-well plates (2.5 × 105 cells/well) were transfected with 400
ng pAAV-EGFP-MMEJ, 100 ng pMA-STAT3-gRNA, 100 ng pMA-
MMEJ-gRNA, 300 ng pSpCas9(BB)-2A-Puro (PX45968) and 100 ng
pNeDaKo-Neo employing XtremeGENETM 9 DNA transfection
reagent according to the manufacturer’s instructions. Cells were
passaged to a 10 cm petri dish 24 h later and after an additional
24 h, the medium was supplemented with 0.7 µg/mL G418 for
10 days. G418-resistant cells were further expanded and enriched
for EGFP-positive cells by ﬂuorescence-activated cell sorting (FACS
core facility, Aarhus University). SKOV3-EGFP-STAT3 cells derived
from a single-cell clone were identiﬁed and validated by Sanger
sequencing and immunostaining.
Labeling of lysosomes and other organelles
Organelles were visualized 2–3 days after transfection with the
indicated plasmids encoding appropriate organelle markers fused
to BFP, i.e., pLAMP1-BFP or pLAMP2-BFP for lysosomes,
mTagBFP2-MannII-N-10 for Golgi,69 mTagBFP2-Rab5a-7 for early
endosomes,69 mito-BFP for mitochondria,65 and BFP-KDEL for
endoplasmatic reticulum.65 Alternatively, lysosomes were visua-
lized by loading the cells with 0.4 mg/mL cascade blue dextran
(10 kDa) or 0.25 mg/mL AlexaFluor 594-dextran (10 kDa) for 1 h in
37 °C cell incubator, followed by washing with Dulbecco′s
phosphate-buffered saline (DPBS) and 5 h incubation in 37 °C cell
incubator. The samples were then analyzed either live or after
20min ﬁxation in 4% paraformaldehyde (PFA) with Zeiss LSM700
confocal laser scanning microscope with 60× objective.
Subcellular fractionation and lysosome puriﬁcation
Subconﬂuent cells grown in 15 cm petri dishes in 20 mL complete
medium were treated for 24 h with 2 mL iron-dextran solution
(53 mg/mL in deionized water; prepared essentially as described
previously70), washed in DPBS, and cultured for additional 24 h in
complete medium. Then, cells were scraped off, washed in DPBS,
and ruptured on ice in SCA buffer (20 mM Hepes-KOH, pH 7.5,
10mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 250 mM
sucrose) with freshly added 1× protease inhibitor cocktail using a
Dounce glass homogenizer (BioVision, 1998-1) until ~90% of cells
were permeable for trypan blue. Ruptured cells were centrifuged
at 1,000× g for 10min at 4 °C. Nuclear pellets were lysed in TBS
lysis buffer (50 mM Tris-Cl, pH 7.5, 150mM NaCl, 0.5% CHAPS, 1%
octyl-β-glucoside) with 1× protease inhibitor cocktail and the
supernatant containing cytosol and organelles was loaded to LS
MACS Separation Columns on octoMACSTM Separator magnet
stand. First, 1 mL of eluate was collected, columns were washed
twice with 0.5 mL SCA buffer, and lysosomes were eluted with 1
mL SCA buffer after removing the columns from the magnet. Both
eluates were centrifuged at 20,000× g for 20 min, supernatant
from the ﬁrst eluate (cytosol) was collected and pellets (organelles
without lysosomes and lysosomes) were lysed in TBS lysis buffer
with 1× protease inhibitor cocktail.
Alternatively, lysosomes were immunopuriﬁed with anti-LAMP1
antibodies. Subconﬂuent cells growing on petri dishes were
scraped in ice-cold DMEM, washed three times with cold
Fig. 6 STAT3 regulates cytosolic pH. a Intensity of lysosomal RFP-STAT3 in A549-RFP-STAT3 cells loaded with 0.4 mg/ml cascade blue dextran
for 1 h, chased for 5 h, and treated with EBSS for 4 h, 0.1 µM baﬁlomycin A1 or 10 µM niclosamide for 1 h, 25 µM EIPA in the absence of NaHCO3
or the presence of 50mM propionate for 0.5 h, or with 1mM LLOMe for 15 min. Histograms show mean lysosomal RFP intensities/cell (top)
and distribution of lysosomal RFP intensities in a cell population (bottom). Representative images of live cells taken with 60× magniﬁcation
using Zeiss LSM700 confocal microscope are shown on the right. Scale bar, 10 µm. b Representative immunoblots of LAMP1 and STAT3 in
lysosomal lysates of HeLa cells left untreated or treated as in a, except for LLOMe treatment that was for 1 h. The histogram shows relative
ratios of STAT3/LAMP1. Cytosolic acidiﬁcation caused by these treatments is shown in Supplementary information, Fig. S6a. c Representative
immunoblots of the indicated proteins in lysates of HeLa cells treated as in b. The histogram shows relative ratios of P-Y705-STAT3 and P-S727-
STAT3. d Representative immunoblots of the indicated proteins in lysates of HeLa cells treated with 25 µM EIPA+ 50mM propionate for the
indicated times. CCND1, cyclin D1; BIRC5, survivin. n= 3. e Quantitative PCR analysis of CCND1 mRNA levels in HeLa cells left untreated or
treated with 25 µM EIPA+ 50mM propionate for 4 h. ACTA1 mRNA served as an internal control. f Quantiﬁcation of STAT3/LAMP2 ratios in
immunoblots of proteins from lysosomes immunopuriﬁed with anti-LAMP1. See Supplementary information, Fig. S6d for a representative blot.
g Quantiﬁcation of PLA (anti-STAT3 and anti-ATP6V1A) puncta in MCF7-vector and MCF7-p95DNErbB2 cells. Error bars, SD of ≥ 3 independent
experiments. P-values were calculated by one-way ANOVA combined with Dunnett’s multiple comparisons test (b, c, d, f and g) or by two-
tailed, homoscedastic Student’s t-test (e) in comparison with the untreated cells
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phosphate-buffered saline (PBS), and resuspended in SCA-low
EDTA buffer (250 mM sucrose, 20mM Hepes, 10mM KCl, 1.5 mM
MgCl2, 0.1 mM EDTA, 1 mM EGTA, pH 7.5) with freshly added
protease and phosphatase inhibitor cocktail. Cell suspension (6 ×
107 cells in 800 µL) was homogenized in gentleMACS using
program “tissue: h_mito_tissue_01” and centrifuged at 750× g for
5 min at 4 °C. The supernatant (light membrane fraction) was
collected and rotated with 0.225 µg primary antibody at 4 °C for
15min before adding 10 µL MicroBeads coupled to goat anti-
rabbit antibody for 1 h. The suspension (3× 150 µL) followed by
500 µL SCA-low EDTA buffer was applied to MS Columns
equilibrated with SCA-low EDTA buffer supplemented with 25 U/
mL benzonase in the magnetic ﬁeld of the octoMACSTM Separator.
After removing the column from the magnetic stand, lysosomes
were eluted with 3× 100 µL SCA-low EDTA buffer.
Immunodetection
Immunoblotting. Cells were lysed in Laemmli sample buffer (125
mM Tris, pH 6.7, 20% glycerol, 140mM SDS) supplemented with
complete protease inhibitor cocktail. After addition of 0.05 M
dithiothreitol and bromophenol blue, boiling and separation by
4%–20% gradient SDS-polyacrylamide gel electrophoresis, pro-
teins were transferred onto polyvinylidene diﬂuoride membranes
using Bio-Rad Trans-Blot Turbo system. Membranes were blocked
with PBS containing 5% milk and 0.1% Tween-20, and stained with
the indicated primary antibodies and appropriate peroxidase-
conjugated secondary antibodies listed in Supplementary infor-
mation, Table S1. CTSB antibody was kindly provided by
Dr Ekkehard Weber (Martin Luther University Halle-Wittenberg,
Halle, Germany).71 The signal was detected with Clarity Western
ECL Substrate and Luminescent Image Reader, and quantiﬁed by
densitometry with Image Studio Lite software.
Immunocytochemistry. Cells grown on glass coverslips were ﬁxed
with 4% PFA or ice-cold methanol, quenched with 50 mM
ammonium chloride in DPBS, permeabilized and blocked in 5%
goat serum, 1% bovine srum albumin (BSA) in DPBS supplemen-
ted with 0.3% Triton X-100 or 0.1% saponin, and stained with the
indicated primary and secondary antibodies listed above. Cover-
slips were mounted with Prolong Gold Antifade mounting
medium with DAPI. Images were acquired using a Zeiss LSM700
microscope with Plan-Apochromat 63×/1.40 Oil DIC M27 objective
and Zen 2010 software (all equipment and software from
Carl Zeiss, Jena, Germany). Pinholes were set so that the
section thickness was equal for all channels and ≤ 1 AU. Cell
contours (n > 20) were deﬁned manually and green and red
thresholds were set up in single channel mode and retained for all
samples in an experiment. SR-SIM was performed using a 63×, 1.4
numerical aperture, oil-immersion objective lens, and an sCMOS
PCO.edge camera mounted on an Elyra PS.1 microscope. Samples
were illuminated with 488 and 561 nm lasers passed through
diffraction gratings of 34 and 42 µm, respectively. Processing was
performed with Zen software black edition 2012 and the channels
were aligned in x, y, z according to a matrix calculated with an
image of 100 nm beads recorded in the same conditions as the
sample. Three-dimensional analyses were done by Fuji software
and remodeling was done by Zen 2012 black software.
Immunoprecipitation. Cells washed with PBS and scraped off in
SCA buffer supplemented with 1× protease inhibitor cocktail, were
ruptured using a Dounce glass homogenizer until ~90% of cells
were permeable for trypan blue. The supernatant obtained after
10min centrifugation at 1,000× g at 4 °C was further centrifuged at
20,000× g for 20min at 4 °C and the pellet (organelles) was lysed
in TBS lysis buffer supplemented with 1× protein phosphatase and
protease inhibitor cocktails on ice. The obtained lysate (150 µg
protein) was precleared by 1 h incubation with 10 µL control IgG
conjugated with magnetic beads and the supernatant aspirated
on magnetic stand was rotated for 2 h with 20 µL speciﬁc
antibodies (rabbit anti-HA or mouse anti-FLAG) or appropriate
control IgG conjugated to magnetic beads at 4 °C. Magnet-puriﬁed
beads were washed three times with TBS lysis buffer, once with
TBS with 300mM NaCl at 4 °C, and proteins were eluted in 25 µL
Laemmli lysis buffer for 5 min at 95 °C before immunoblot analysis.
Proximity ligation assay. PLA assay was performed with Duolink
In Situ Red Starter Kit according to the manufacturer’s instructions.
Brieﬂy, cells grown on coverslips were ﬁxed with 4% PFA for 20
Fig. 7 Lysosomal STAT3 protects cells against cytosolic acidiﬁcation.
a Cytosolic pH in the indicated HeLa clones determined by image
analysis of cells loaded with pHrodo™ Green AM. Standard curve is
displayed on the right. b, c Cell death of the indicated HeLa cell
clones (b) and HeLa-STAT3-KO-11 cells transiently transfected with
vector or STAT3-Y705F (c) left untreated, starved in EBSS for 6 h, or
treated with 25 µM EIPA+ 50mM propionate for 24 h was deter-
mined by propidium iodine uptake. Error bars, SD of ≥ 3
independent experiments. P-values were calculated by one-way
ANOVA combined with Dunnett’s multiple comparisons test (a, b) or
by two-tailed, homoscedastic Student’s t-test (c)
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min, permeabilized in buffer 1 (PBS with 1% BSA and 0.3% Triton
X-100) for 10 min and blocked in Duolink blocking buffer. Samples
were then incubated for 18 h at 4 °C with the indicated primary
antibodies diluted in buffer 1 supplemented with 5% goat serum,
washed 3× 5min in buffer 1, and incubated with Duolink
secondary antibodies for 1 h at 37 °C. After washing 2× 5min in
Duolink washing buffer A, samples were incubated for 30 min at
37 °C with 1:40 dilution of Duolink ligase in Duolink ligation buffer
and washed 2× 2min in Duolink washing buffer A. Finally, samples
were incubated for 100 min at 37 °C with 1:80 dilution of Duolink
polymerase in Duolink ampliﬁcation buffer, washed for 2× 10min
in 1× Duolink washing buffer B and for 1 min in 0.01× washing
buffer B, and mounted with ProLong™ Gold Antifade Mountant.
Images were taken by LSM700 with 60×magniﬁcation and
analyzed by open source Image J software.
In vivo crosslinking
In vivo crosslinking was performed by incubating cells in 3 mL
fresh culture media containing 2.5 mM dithiobis(succinimidyl
propionate) (DSP) for 10 min at 37 °C and 5% CO2. DSP was
quenched by adding 330 µL of 1 M Tris-HCl (pH 8.0) and
incubating for another 10 min. After two washes with cold PBS,
cells were lysed in 500 µl TBS lysis buffer supplemented with 1×
protease and phosphatase inhibitor cocktails on ice for 20min.
Protein identiﬁcation by mass spectrometry
Anti-FLAG immunoprecipitation from lysates of lysosomal extracts
from HeLa cells transfected with pBCMV-STAT3-Flag-puro or
empty vector 3 days earlier, and anti-STAT3 and mIgG2a
immunoprecipitation from total lysates of HeLa cells after in vivo
crosslinking were performed according to the protocol described
above. Interacting proteins were identiﬁed and quantiﬁed by
nano-LC-MS/MS, essentially as previously described.72 Brieﬂy, each
gel lane was cut into 1× 1mm pieces and cysteine residues were
blocked by reduction and alkylation using tris(2-carboxyethyl)
phosphine and iodoacetamide, respectively. In-gel digestion was
performed using trypsin and resulting peptides were extracted
from gel pieces using acetonitrile and triﬂuoroacetic acid, and
ﬁnally puriﬁed on PepClean C-18 Spin columns. LC-MS/MS was
performed on an EASY nanoLC coupled to a Q Exactive Plus
Hybrid Quadrupole-Orbitrap Mass Spectrometer. Peptide samples
were separated on a PepMap C-18 reverse phase column (25 cm
length, 75 µm inner diameter, and 2 μm particle size) and eluted
by a 90min linear gradient of acetonitrile (4%–40%) containing
0.1% formic acid. The MS was operated in a data-dependent
mode, automatically switching between MS and MS2 acquisition,
with mass resolution of 70,000 and 17,500, respectively. Up to ten
most intense ions were fragmented per every full MS scan by
higher-energy collisional dissociation. Dynamic exclusion of 10 s
was applied and ions with single charge or unassigned charge
states were excluded from fragmentation. MaxQuant software
version 1.5.2.8 was applied for protein identiﬁcation and label-free
quantiﬁcation by means of peptide peak areas.73 The MS raw ﬁles
were searched against a database consisting of 20,197 Homo
sapiens protein sequences downloaded from UniProt.74 Carbami-
domethylation of cysteines was set as ﬁxed modiﬁcation, whereas
methionine oxidation and protein N-terminal acetylation were set
as dynamic modiﬁcations. The false discovery rate (FDR) was
assessed by searching against a reverse decoy database75 and FDR
thresholds of protein and peptide identiﬁcation were both set
to 0.01.
pH measurements
Lysosomal pH was estimated based on the ﬂuorescence intensity
ratio of pH-sensitive FITC and pH-insensitive TMR essentially as
described previously.36 In brief, cells were loaded with 2.5 mg/mL
70 kDa dextran coupled to FITC and TMR in complete medium for
18 h, washed with DPBS, and incubated for additional 5 h with
complete medium without dextran. Images of dextran-loaded
cells were acquired by LSM700 confocal laser scanning micro-
scope (Zeiss) and the FITC/TMR ratio was calculated by open
source Image J software. Standard curves used to estimate
lysosomal pH were created by similar analysis of cells incubated
with a series of Hepes buffers (145 mM KCl, 10 mM glucose, 1 mM
MgCl2, 10 µM nigericin, 20mM Hepes) with pH ranging from 4.5 to
7.0. After transient transfections, pH changes were expressed as
arbitrary units based on FITC/TMR ratio, the lower ratio indicating
higher pH.
The relative volume of the acidic compartment of trypsinized
cells stained for 5 min with 75 nM Lysotracker Green DND-26 and
washed in PBS was estimated by ﬂow cytometry analysis
employing BD FACSVerse™ instrument. Data were collected with
BD FACSuite v1.0.6 and analyzed by Flowjo V10 software.
To estimate the cytosolic pH, cells washed with Live Cell
Imaging Solution were incubated for 30 min in 37 °C in the same
solution containing 1:1,000 dilution of pHrodo™ Green AM
Intracellular pH Indicator and 1:100 dilution of PowerLoad™
concentrate, washed with Live Cell Imaging Solution, and
analyzed by LSM700 confocal laser scanning microscope. Standard
curves used to estimate cytosolic pH were created by similar
analysis of cells incubated with a series of pH calibration buffers
(pH 4.5, 5.5, 6.5, and 7.5) supplemented with 10 µM valinomycin
and 10 µM nigericin (Intracellular pH Calibration Kit).
STAT3 recombinant protein generation
To produce recombinant N-terminally truncated and C-terminally
superfolder-GFP-tagged STAT3 (ΔN-STAT3-sfGFP), the sequence
coding for amino acid residues 127–770 of STAT3 was PCR
ampliﬁed with primers listed in Supplementary information,
Table S2 and ligated into the cloning site of the pETM11SU-
MO3sfGFP vector. The obtained pETM11SUMO3ΔNSTAT3sfGFP
plasmid was used to transform competent E. coli BL21 StarTM(DE3)
cells. After 18 h shaking at 16 °C, cells were lysed in the lysis buffer
(50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 20 mM imidazole, 0.5 mM
dithiothreitol (DTT)) supplemented with 1× complete EDTA-free
protease inhibitor cocktail, 1× BugBuster Protein Extraction
Reagent, and 50 units/mL Benzonase Nuclease, and centrifuged
at 21,000× g for 45 min at 4 °C. The supernatant was ﬁltered
(0.2 µm) and passed through Ni-NTA afﬁnity resins (Qiagen,
30210), which were washed in lysis buffer before elution of N-
terminally hexahistidine- and SUMO3 domain-tagged recombi-
nant ΔN-STAT3sfGFP protein in Tris buffer (50 mM Tris-HCl, pH 7.5,
250mM NaCl) supplemented with 300 mM imidazole. The protein
was dialyzed against Tris buffer overnight at 4 °C in the presence
of 200:1 (mol:mol) of in house-puriﬁed SenP2 protease to cleave
off the N-terminal tags. Finally, the protein was loaded on
the Superdex 200 size-exclusion chromatography column
(GE Healthcare), and the fractions containing the ΔN-STAT3sfGFP
were pooled and stored at −80 °C. sfGFP control protein was
prepared in a similar manner using pETM11SUMO3sfGFP vector
for transformation.
V-ATPase assay
To purify V-ATPase, two 15 cm petri dishes with subconﬂuent
HeLa cells were transfected with pCDNA3.1HA-ATP6V1A plasmid
(5 µg/plate). Three days later, cells were scraped off in SCA buffer
supplemented with 1× protease inhibitor cocktail and ruptured
using a Dounce glass homogenizer until ∼90% of cells were
permeable for trypan blue. Ruptured cells were centrifuged at
1,000× g for 10 min and the obtained supernatant was further
centrifuged at 20,000× g for 20 min. The pellet was lysed in 450 µL
TBS lysis buffer supplemented with 1× protease inhibitor cocktail,
incubated on ice for 30 min, and centrifuged at 20,000× g for
1 min. After determining the protein concentration, the super-
natant containing 150 µg protein was precleared by rotation with
12 µL magnetic bead-conjugated rabbit IgG for 1 h at 4 °C. The
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precleared supernatant aspirated on magnetic stand was then
rotated with 20 µL magnetic bead-conjugated rabbit mAb against
HA for 2 h at 4 °C and the supernatant was aspirated on magnetic
stand. The beads were washed 3× 5min in 500 µL of TBS lysis
buffer and suspended in 50 µL of V-ATPase reaction buffer (40 mM
HEPES, pH 7.5, 1 mM MgCl2, 100mM KCl, 0.25 mM Sucrose, 5 µg/
mL Oligomycin, 1 mM DTT) supplemented with 1× protease
inhibitor cocktail.
To measure the V-ATPase activity, 15 µL anti-HA beads (V-
ATPase) were mixed with 4.5 µg ΔN-STAT3sfGFP or 4.5 µg sfGFP
(negative control) and the volume was adjusted to 150 µL with V-
ATPase reaction buffer. The reaction was started by adding 1mM
ATP (ﬁnal concentration) and incubating the samples for 30min at
30 °C. The samples and free phosphate standard dilutions were
then transferred to 96-well plates (50 µL/well) and the reactions
were stopped by adding 100 μL BIOMOL Green Reagent. Plates
were incubated at 25 °C for 20–30min before determining
OD620nm in a Varioskan Flash Multimode Reader. The amount
of ATP hydrolyzed was calculated using the standard curve created
by the free phosphate dilutions analyzed on the same plate.
Dextran degradation assay
Subconﬂuent cells were loaded with 0.4 mg/mL AlexaFluor 488-
dextran (10 kDa) for 20 min and washed twice with PBS. The
samples for the analysis of AlexaFluor 488-dextran uptake were
then ﬁxed with 4% PFA for 20min, whereas the parallel samples
for the analysis of AlexaFluor 488-dextran degradation were
incubated in complete medium for additional 4 h before ﬁxation.
Images were acquired using a Zeiss LSM700 microscope with EC
Plan-Apochromat 63×/1.40 Oil DIC M27 objective. Fluorescence
intensities were determined by open source Image J software.
RNA sequencing
The mRNA and non-coding RNAs were enriched by removing
rRNA with RNaseH. Target RNAs were fragmented into short
fragments in the fragmentation buffer and cDNAs were synthe-
sized using the RNA fragments as templates for N6 random
primer, followed by end reparation and ligation to adapters. The
quantity and quality of the cDNA libraries were assessed using an
Agilent 2100 BioAnalyzer. Finally, the libraries were sequenced on
the BGISEQ-500 with 50 single-end read.
Sequencing reads that contained adapters, had low quality, or
aligned to rRNA were ﬁltered off before mapping. Clean reads
were aligned to the hg19 UCSC RefSeq (RNA sequences, GRCh37)
using bowtie2. Fragments per kilobase of transcript per million
mapped reads values were obtained by transforming mapped
transcript reads using RSEM. Differential expression analysis was
performed by DESeq2. Differentially expressed genes were
deﬁned as genes with fold change ≥ 1.5 and P-value ≤ 0.05. Clean
reads were mapped to the hg19 genome using hisat2.
Quantitative PCR
qPCR was performed using SuperScript™ III Platinum™ SYBR™
Green One-Step qPCR Kit according to the manufacturer’s
instructions.
Identiﬁcation of STAT3 target genes
Putative STAT3 target genes were deﬁned by annotating the 2001
common peaks from the STAT3 ChipSeq datasets
GSM935276_hg19_wgEncodeSydhTfbsHelas3Stat3IggrabPk.nar-
rowPeak.gz and GSM935591_hg19_wgEncodeSydhTfbsMcf10aes-
Stat3Etoh01StdPk.narrowPeak.gz from HeLa-S3 and MCF10A-Er-
Src cells, respectively, to promoter sequences 2 kb upstream and
1 kb downstream of transcription start sites.
Cell death assay
Cells (5 × 103) plated on 96-well plates were treated as indicated,
and stained with 3 µg/mL propidium iodide and 5 µg/mL Hoechst
33342 for 1 min. Percentage of dead cells (propidium iodide
positive/Hoechst positive) of all cells (Hoechst positive) was
quantiﬁed by Celigo Cell Imaging Cytometer.
Quantiﬁcation and statistical analysis
All experiments were performed a minimum of three times and
results are expressed as mean ± SD from ≥ 3 independent
experiments. For all image-based analyses, ≥ 10 randomly chosen
cells/sample were analyzed. Data obtained from the lysotracker
staining, PLA, lysosomal pH measurements, and cell death assays
comparing multiple genetically modiﬁed clones were analyzed
using one-way ANOVA with multiple comparison by Dunnett’s
multiple comparisons test. Cathepsin maturation examined by
western blotting and lysosomal pH measurement in HMF3 cells
were analyzed using one-way ANOVA with multiple comparison
by two-stage linear step-up procedure of Benjamini, Krieger, and
Yekutieli. Signiﬁcance of differences in mRNA expression levels
analyzed by RNA sequencing (RNA-Seq) were deﬁned by DEseq2.
Other data were analyzed using by two-tailed, homoscedastic
Student’s t-test.
Data resources
The MS proteomics data have been deposited to the ProteomeX-
change Consortium (www.ebi.ac.uk/pride) via the PRIDE76 partner
repository with the dataset identiﬁer PXD006788. GEO accession
number for RNA-Seq data is GSE108495. Other datasets generated
during the current study will be available from the corresponding
author upon reasonable request.
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